Compumedics Limited (ASX:CMP)
Australia · Delayed Price · Currency is AUD 0.2550
0.00 (0.00%)
Aug 28, 2026, 1:18 PM AEST
Compumedics Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 51 | 51 | 49 | 59 | 32 | 27 | |
Market Cap Growth | -6.93% | 4.02% | -17.49% | 86.11% | 16.13% | -60.76% |
Enterprise Value | 59 | 62 | 58 | 65 | 36 | 26 |
Last Close Price | 0.26 | 0.26 | 0.26 | 0.34 | 0.18 | 0.15 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 255.00 | 238.03 | - | - | - | 20.24 |
Forward PE | 12.14 | 8.10 | 11.59 | 11.41 | 11.41 | 11.41 |
PS Ratio | 0.82 | 0.82 | 0.96 | 1.18 | 0.74 | 0.71 |
PB Ratio | 2.24 | 2.24 | 2.26 | 3.26 | 1.74 | 1.16 |
P/TBV Ratio | 2.24 | 2.24 | 2.26 | 3.26 | 1.74 | 1.16 |
P/FCF Ratio | 7.93 | 7.93 | 210.17 | 35.16 | - | 10.28 |
P/OCF Ratio | 7.71 | 7.71 | 109.55 | 29.66 | 650.80 | 8.35 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.95 | 1.01 | 1.13 | 1.29 | 0.84 | 0.68 |
EV/EBITDA Ratio | 10.50 | 12.94 | 41.15 | 273.86 | - | 17.39 |
EV/EBIT Ratio | 17.27 | 18.28 | 64.25 | - | - | 26.43 |
EV/FCF Ratio | 9.17 | 9.70 | 247.06 | 38.45 | - | 9.77 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.62 | 0.62 | 0.64 | 0.47 | 0.52 | 0.28 |
Debt / EBITDA Ratio | 2.52 | 2.52 | 5.91 | 10.20 | - | 3.09 |
Debt / FCF Ratio | 2.20 | 2.20 | 59.57 | 5.08 | - | 2.45 |
Net Debt / Equity Ratio | 0.35 | 0.35 | 0.52 | 0.37 | 0.31 | -0.03 |
Net Debt / EBITDA Ratio | 1.65 | 1.65 | 8.00 | 28.22 | -2.18 | -0.50 |
Net Debt / FCF Ratio | 1.24 | 1.24 | 48.02 | 3.96 | -6.48 | -0.28 |
Asset Turnover | 1.12 | 1.12 | 1.08 | 1.23 | 1.04 | 0.96 |
Inventory Turnover | 2.07 | 2.07 | 1.64 | 1.98 | 2.04 | 1.90 |
Quick Ratio | 0.68 | 0.68 | 0.65 | 0.61 | 0.89 | 1.36 |
Current Ratio | 1.23 | 1.23 | 1.11 | 1.24 | 1.39 | 1.91 |
Return on Equity (ROE) | 0.96% | 0.96% | -6.35% | -1.85% | -29.23% | 5.93% |
Return on Assets (ROA) | 3.84% | 3.84% | 1.18% | -0.41% | -4.55% | 1.54% |
Return on Invested Capital (ROIC) | 1.43% | 1.38% | 3.10% | 0.78% | -12.90% | 3.58% |
Return on Capital Employed (ROCE) | 12.00% | 12.00% | 4.00% | -1.40% | -15.10% | 4.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 0.42% | 0.42% | -2.59% | -0.57% | -19.20% | 4.94% |
FCF Yield | 12.61% | 12.61% | 0.48% | 2.84% | -2.74% | 9.73% |
Buyback Yield / Dilution | -13.67% | -13.67% | -6.26% | - | - | - |